Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDDK

ADENOSINE FUNCTIONALIZED CONGENERS AS CARDIOVASCULAR TREATING AGENTS FOR ANIMALS

  • Read more about ADENOSINE FUNCTIONALIZED CONGENERS AS CARDIOVASCULAR TREATING AGENTS FOR ANIMALS
US Patent 5,284,834
Filed on 1992-08-06

DNA SEQUENCE WHICH ACTS AS A CHROMATIN INSULATOR ELEMENT TO PROTECT EXPRESSED GENES FROM CIS-ACTING REGULATORY SEQUENCES IN MAMMALIAN...

  • Read more about DNA SEQUENCE WHICH ACTS AS A CHROMATIN INSULATOR ELEMENT TO PROTECT EXPRESSED GENES FROM CIS-ACTING REGULATORY SEQUENCES IN MAMMALIAN...
US Application 08/045,266
Filed on 1993-04-07

HIGH EFFICIENCY PACKAGING OF MUTANT ADENO-ASSOCIATED VIRUS USING AMBER SUPPRESSION

  • Read more about HIGH EFFICIENCY PACKAGING OF MUTANT ADENO-ASSOCIATED VIRUS USING AMBER SUPPRESSION
US Application 07/896,910
Filed on 1992-06-11

EXPRESSION OF A HETEROLOGOUS PEPTIDE IN MAMMARY TISSUE OF TRANSGENIC NON-HUMAN MAMMALS USING A LONG WHEY ACID PROTEIN PROMOTER

  • Read more about EXPRESSION OF A HETEROLOGOUS PEPTIDE IN MAMMARY TISSUE OF TRANSGENIC NON-HUMAN MAMMALS USING A LONG WHEY ACID PROTEIN PROMOTER
US Patent 5,831,141
Filed on 1992-09-10

CLONING AND FUNCTIONAL EXPRESSION OF CHOLECYSTOKININ RECEPTOR-ENCODING DNA

  • Read more about CLONING AND FUNCTIONAL EXPRESSION OF CHOLECYSTOKININ RECEPTOR-ENCODING DNA
US Application 07/928,033
Filed on 1992-08-11

METHOD OF CLEAVING SPECIFIC STRANDS OF RNA

  • Read more about METHOD OF CLEAVING SPECIFIC STRANDS OF RNA
US Application 07/965,666
Filed on 1992-10-21

METHOD FOR THE TREATMENT OF PARKINSON'S DISEASE

  • Read more about METHOD FOR THE TREATMENT OF PARKINSON'S DISEASE
US Patent 5,284,654
Filed on 1992-06-03

RNA TEMPLATE-SPECIFIC POLYMERASE CHAIN REACTION.

  • Read more about RNA TEMPLATE-SPECIFIC POLYMERASE CHAIN REACTION.
US Application 07/882,253
Filed on 1992-05-08

Modified Adeno-Associated Virus Vector Capable of Expression from a Novel Promoter

  • Read more about Modified Adeno-Associated Virus Vector Capable of Expression from a Novel Promoter
US Patent 5,587,308
Filed on 1992-06-02

METHOD FOR THE TREATMENT OF HEMOPHILIA A AND B

  • Read more about METHOD FOR THE TREATMENT OF HEMOPHILIA A AND B
US Application 07/941,573
Filed on 1992-09-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 147
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDDK
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health